Additionally, earlier studies also show that TGF-β can suppress the basal expression of several genes in hepatoma cells and can even potentially inhibit few IL-6-induced genes, which is important from the perspective of manipulating cytokine balance as a prospective therapeutic strategy (69). The gene discussed is IL6; the disease is hepatocellular carcinoma.